Search

everythinglearnresearchcommunity

for

Search:↓

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

PRP injections effectively improve hair growth in androgenic alopecia.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Finasteride helps reduce heart issues and improves heart function.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Minoxidil can cause a rare but serious condition that leads to fluid buildup around the heart and drug-induced lupus.

No genetic link between prostaglandins and hair loss found.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Minoxidil promotes hair growth but exact mechanism is unknown.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Cyclosporin doesn't stop hair loss.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Hair loss in men is common, treatable, but not curable.

Hair loss needs more research for better treatments.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.